Alzheimer's Disease: Causes, Pathology, and Symptoms

Added:

The Pathogen and Metabolic Hypotheses of Alzheimer's

While mainstream research has long focused on the 'Amyloid Cascade Hypothesis'—which views beta-amyloid plaques as the primary initiator of Alzheimer's pathology—this paradigm faces scrutiny due to the historical failure of amyloid-targeting drugs to halt cognitive decline. Alternative perspectives suggest that plaques are a symptom, not the root cause. The 'Pathogen Hypothesis' argues that chronic brain infections (such as HSV-1 or gum bacteria) trigger Alzheimer's, and that beta-amyloid actually functions as a protective antimicrobial peptide. Meanwhile, the 'Metabolic Hypothesis' (sometimes called 'Type 3 Diabetes') posits that the disease is primarily a metabolic disorder driven by brain insulin resistance and mitochondrial dysfunction, which impairs energy production and causes synaptic loss. These theories shift the therapeutic focus from plaque removal to managing infections, inflammation, and metabolic health.

Basic neuroanatomy, specifically the structure of a neuron (axon, dendrites, synapses) and key brain regions like the hippocampus.
The fundamentals of synaptic transmission and how neurotransmitters (particularly acetylcholine) facilitate brain communication.
An understanding of basic protein biology, including protein synthesis, folding, and how misfolded proteins can disrupt cellular function.
Basic principles of genetics, including the difference between inherited mutations and genetic risk factors.
Modern diagnostic techniques for Alzheimer's, including cognitive testing, PET imaging, and cerebrospinal fluid (CSF) biomarkers.
Current and emerging pharmacological interventions, such as cholinesterase inhibitors and monoclonal antibody therapies targeting amyloid-beta.
Differential diagnosis of other forms of dementia, such as Vascular Dementia, Lewy Body Dementia, and Frontotemporal Dementia.
The role of lifestyle factors (diet, sleep, cognitive reserve, and cardiovascular health) in the prevention and management of cognitive decline.
1.9M views33.2Klikes8:54@osmosisOriginal Release: 2016-03-22

Alzheimer's disease is a neurodegenerative disorder characterized by the accumulation of beta-amyloid plaques (formed when beta-secretase cleaves amyloid precursor protein, creating sticky amyloid beta monomers that clump outside neurons) and neurofibrillary tangles (formed when tau proteins become hyperphosphorylated and detach from microtubules inside neurons), leading to neuronal dysfunction, brain atrophy, and progressive cognitive decline; the disease has sporadic (late-onset, influenced by APOE-e4 allele) and familial (early-onset, caused by PSEN-1/PSEN-2 mutations or Down syndrome) forms, with no definitive cure currently available.